Durvalumab vs Losartan

Durvalumab vs Losartan: Overview

This comparison examines the pharmacological differences between Durvalumab and Losartan.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Losartan: Angiotensin II receptor type 1 antagonist.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Losartan — 2 hours.

Chemical Properties

Molecular Formula: Losartan — C22H23ClN6O.

Molecular Weight: Losartan — 422.9200 g/mol.

Type: Durvalumab — Antibody; Losartan — Small molecule.